NCT06500611 Combined Effects Of Sensory Integration And Vestibular Exercises On Post-Stroke Patients
| NCT ID | NCT06500611 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Post Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2025-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2024-07-10 with a primary completion date of 2025-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the combined effects of sensory integration and vestibular exercise on dizziness, fall risk and quality of life.
Eligibility Criteria
Inclusion Criteria: * Both male and female * Age between 40years-65years * those who have been diagnosed with vestibular disorders * An ability to stand for for 5 minutes without aid measured by 5 times sit to stand test. Exclusion Criteria: * Have bilateral or unstable vestibular loss * Any neurological condition is present * Active BPPV is present * Any acute orthopaedic condition is present * Peripheral neuropathy is present * Visual impairment not corrected with glasses.
Contact & Investigator
Aruba Saeed, Phd*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06500611 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Post Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06500611 currently recruiting?
Yes, NCT06500611 is actively recruiting participants. Contact the research team at saifazia@ymail.com for enrollment information.
Where is the NCT06500611 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06500611 clinical trial?
NCT06500611 is sponsored by Riphah International University. The principal investigator is Aruba Saeed, Phd* at Riphah International University. The trial plans to enroll 38 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.